MARKET INTRODUCTION

Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior.

MARKET DYNAMICS

Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors such as growing prevalence of depression, rising geriatric population, and emergence of novel techniques for the development of drugs. Moreover, rising investments in R&D by the public and private sector, and increase in number of patent expiration of antidepressants are also offering opportunities in the market growth during the forecast period.

MARKET SCOPE

The "Global Anti-Depressant Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-depressant drugs market with detailed market segmentation by product, depression disorder, and geography. The global anti-depressant drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading anti-depressant drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global anti-depressant drugs market is segmented on the basis of product and depressive disorder. Based on product, the market is segmented as tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, and others. Based on depressive disorder, the market is segmented as major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global anti-depressant drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-depressant drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anti-depressant drugs market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-depressant drugs market in these regions.

MARKET PLAYERS

The report covers key developments in the anti-depressant drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti-depressant drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for anti-depressant drugs in the global market. Below mentioned is the list of few companies engaged in the Analgesics market.

The report also includes the profiles of key anti-depressant drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Alkermes Plc,
- Allergan Plc,
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- H. Lundbeck
- Merck & Co., Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.